All News

Danil V. Makarov, MD, MHS, presents the take home messages on outcomes analysis.

A study of more than 1,800 men ages 52 to 62 years suggests that African-Americans diagnosed with very low-risk prostate cancers are much more likely than Caucasian men to actually have aggressive disease that goes unrecognized with current diagnostic approaches.

Edmund Chiong, MD, presents the take home messages on bladder cancer from the AUA annual meeting in San Diego.

The use of advanced treatments-namely, intensity-modulated radiation therapy and robotic prostatectomy-in patients with low-risk prostate cancer has increased significantly, despite little evidence of benefit, according to a recently published study from the University of Michigan Comprehensive Cancer Center, Ann Arbor.

Andrew Wagner, MD, presents the take home messages on kidney cancer from the AUA annual meeting in San Diego.

Newly elected AUA President Pramod C. Sogani, MD, discusses the AUA's new regional courses on advanced prostate cancer treatment and its expanded course offerings in urologic ultrasound, among other topics.

A new prognostic test for prostate cancer outperformed existing risk assessment tools for predicting metastatic disease in patients following radical prostatectomy, researchers reported.

Caldera Medical has announced FDA clearance and the launch of Vertessa Lite, which Caldera calls a supple, lightweight, yet strong polypropylene mesh for use in abdominal sacrocolpopexy procedures for vaginal vault prolapse.

Aaron Spitz, MD, presents the take home messages on infertility/andrology from the AUA annual meeting in San Diego.

Jeannette M. Potts, MD, presents the take home messages on infection and inflammation at the AUA annual meeting in San Diego.

Jay D. Raman, MD, presents the take home messages on prostate cancer from the AUA annual meeting in San Diego.

Physicians and their advocates scored important victories in Connecticut, Florida, and Georgia in working to defeat attempts to undermine past medical liability reform successes and achieving new ones.

Estrogen supplements may help menopausal women ward off recurrent urinary tract infections, researchers recently reported.

Observation appears to be safe and more cost effective than immediate treatment for many men with low-risk, localized prostate cancer, according to a recent study from Dana-Farber Cancer Institute and Massachusetts General Hospital, Boston.

The need to equalize or narrow Medicare payment differences between ambulatory services provided in hospital outpatient departments (OPDs) and physicians’ offices is urgent, according to the Medicare Payment Advisory Commission (MedPAC).

Early exposure to bisphenol A (BPA) leads to an increased cancer risk in an animal model of human prostate cancer, according to new research findings from the University of Illinois at Chicago.

The amount of money that has been spent by payers and vendors with deep lobbying pockets has made the delay of ICD-10 implementation highly unlikely. As such, we are recommending that every practice assume that Oct. 1, 2014 is the implementation date.

“Our group all felt that we were caught off guard," said one urologist about the AUA's new prostate cancer screening guideline.

A relatively new imaging system demonstrates a higher capacity for mapping recurrent prostate cancer than integrated positron emission tomography and computed tomography, researchers recently reported at the Society of Nuclear Medicine and Molecular Imaging annual meeting in Vancouver, British Columbia.

The use of computed tomography scans of the head, abdomen/pelvis, chest, or spine in children younger than 14 years of age more than doubled from 1996 to 2005, according to a study of seven U.S. health care systems.

Men with prostate cancer may significantly improve their survival chances with a simple change in their diet, according to a recent study.

AVEO Oncology recently announced that it has received a complete response letter from the FDA informing the company that the FDA will not approve in its present form the new drug application for AVEO’s investigational agent tivozanib for the treatment of patients with advanced renal cell carcinoma.

A new AUA guideline on the early detection of prostate cancer is a PSA-focused, evidence-based guideline intended to assist the urologist in advising an average-risk, asymptomatic man about prostate cancer screening in order to reduce prostate cancer mortality, said H. Ballentine Carter, MD, at the AUA annual meeting in San Diego.

Results from the primary endpoint analysis in a phase III randomized, placebo-controlled study showed that intravenous radium Ra 223 dichloride (Xofigo), an alpha-particle-emitting radiotherapeutic agent and calcium mimetic that binds to newly formed bone stroma, significantly improved overall survival in castration-resistant prostate cancer patients with bone metastases.

The prevalence of urolithiasis in the United States and the cost of its care will increase dramatically in the future if the epidemics of obesity and diabetes mellitus continue unchecked, according to analyses conducted by researchers at the University of Texas Southwestern Medical Center, Dallas.

Among the various choices for saving for college, attention seems to be focused on the section 529 plan.

The complicated landscape of federal and private insurance, fraud and abuse laws, and anti-kickback statutes have created new context for “professional courtesy,” and physicians should be aware of the applicable rules and regulations that could apply to this once-common practice.

Typically, a consultant is brought into a urology practice for a particular project such as conducting an operational assessment, but just as importantly, once the consultant has gained this familiarity with the practice, he/she makes a great mentor.